Communiqués Clover Health Investments, Corp.

Actions

CLOV

US18914F1030

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 15/07/2024			Varia. 5j.	Varia. 1 janv.
1,58 ^USD	+4,64 %		+18,80 %	+65,95 %

26/06	Clover Health Investments se conforme de nouveau à la règle de cotation du Nasdaq	MT
29/05	Clover Health Investments propose l'outil d'IA 'Clover Assistant' en dehors du plan Medicare	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement	26/06	AQ
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year	14/06	AQ
Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers	29/05	AQ
Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability	07/05	AQ
Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference	01/05	AQ
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	30/04	AQ
Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024	23/04	AQ
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer	22/04	AQ
Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions	04/04	AQ
Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness	19/03	AQ
Clover Health's Remarkable Turnaround: A Deep Dive into 2023 Results and 2024 Outlook	14/03	AQ
Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance	12/03	AQ
Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage	07/03	AQ
Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024	26/02	AQ
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	16/02	AQ
An In-Depth Analysis of Humana Inc. and the Shifting Dynamics in Medicare Advantage: Exploring the Potential for Clover Health	29/01	AQ
Clover Health Provides Business Update and Full-Year 2024 Objectives	10/01	AQ
BestGrowthStocks.Com Issues Extensive Comprehensive Analysis of Clover Health Investments, Corp.	10/01	AQ
PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent	08/01	AQ
Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023	21/12	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Clover Health Investments, Corp.

Actions

CLOV

US18914F1030

Communiqués

Filtres